Streetbeat News

Stock Prices

ASND

Ascendis Pharma (NASDAQ:ASND) has significantly outperformed the market over the past decade, delivering an average annual return of 49.72%. A $100 investment in ASND 10 years ago would be worth $5,869.77 today. The company's current market capitalization is $7.20 billion.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 4:30 pm

ANTX

HUGE

HYZN

ITI

MMAT

SATS

VEV

US stocks edged lower with the Dow Jones, NASDAQ, and S&P 500 all falling slightly. EchoStar Corporation shares tumbled 16% after reporting worse-than-expected Q2 results. FSD Pharma, Iteris, and Hyzon Motors saw significant gains, while AN2 Therapeutics, Vicinity Motor, and Meta Materials experienced substantial declines.

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 4:29 pm

MGOL

MGO Global shares have resumed trading after a circuit breaker halt.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 4:29 pm

ELF

E.L.F. Beauty (NYSE:ELF) shares initially traded lower on Friday despite reporting strong fiscal year 2025 first quarter results, beating both EPS and revenue estimates. The company also raised its revenue guidance for the fiscal year. Multiple analysts adjusted their price targets following the earnings report.

Portfolio Pulse from Dylan Berman

August 09, 2024 | 4:22 pm

U

Unity Software Inc. (NYSE:U) shares are rising after the company reported better-than-expected earnings for the 2024 fiscal year second quarter. Unity reported a loss of 32 cents per share, beating the estimated loss of 41 cents per share, and sales of $449.25 million, surpassing the expected $439.45 million. The company provided lower-than-expected revenue guidance for the third quarter and fiscal year. Additionally, Unity announced leadership changes with Mark Barrysmith as interim CFO and Jim Payne as Chief Product Officer for Advertising. Analysts have adjusted their price targets for Unity, with some lowering their targets.

Portfolio Pulse from Dylan Berman

August 09, 2024 | 4:20 pm

CVS

CVS Health Corp (NYSE:CVS) shares are trading 1.52% lower at $56.97 after reporting worse-than-expected Q2 sales and cutting FY24 adjusted EPS guidance. Sales were $91.23 billion, slightly below the $91.51 billion consensus. Adjusted EPS was $1.83, down from $2.21 last year but above the $1.73 consensus. Operating income fell 16.4% to $3.74 billion. The Health Care Benefits segment’s revenues grew by 21.4%, while the Health Services segment’s revenues dropped by 8.8%. CEO Karen Lynch will take direct control of the Health Care Benefits segment. CVS revised its 2024 adjusted EPS guidance to $6.40-$6.65, down from at least $7.00.

Portfolio Pulse from Henry Khederian

August 09, 2024 | 4:20 pm

DBX

Dropbox Inc (NASDAQ:DBX) reported better-than-expected Q2 financial results, leading to mixed analyst reactions. Goldman Sachs reiterated a Sell rating with a lowered price target, while RBC Capital Markets maintained an Outperform rating. Key concerns include user growth, SMB choppiness, and security incidents.

Portfolio Pulse from Anusuya Lahiri

August 09, 2024 | 4:20 pm

GOOG

GOOGL

Google has announced the release of Apache Airflow operators for its Generative AI, aiming to streamline AI workflows and enhance integration with its cloud services.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 4:16 pm

CEG

Whales are showing a bullish stance on Constellation Energy (NASDAQ:CEG) with significant options trades detected. The major market movers are focusing on a price band between $175.0 and $240.0. Analysts have set an average price target of $217.67, with ratings ranging from Outperform to Buy.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 4:16 pm

CVS

Deep-pocketed investors have shown a bearish sentiment towards CVS Health (NYSE:CVS) through significant options activity. Benzinga's options scanner highlighted 8 extraordinary options activities, with 62% of the sentiment being bearish. The price target for CVS Health is between $50.0 and $62.5. Analysts have mixed ratings, with an average price target of $61.25.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 4:15 pm